Clinical-stage company developing gene therapies for severe genetic and rare diseases.
Issues related to novel therapies for rare pediatric populations; H.R. 1628, The American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment; monitored issues related to S.204, the Trickett Wendler Right to Try Act of 2017; monitored issues related to the consideration of S. 934 and H.R. 2430, The FDA Reauthorization Act of 2017. Issues related to Medicaid and CHIP as it relates to rare pediatric diseases. H.R. 1628, The American Health Care Act of 2017 including the Better Care Reconciliation Act and the Graham Cassidy amendment and issues related to Medicaid and high risk populations.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
STACEY HUGHES EMILY PORTER KATHERINE RAAB EMILY PORTER STACEY HUGHES KATHERINE RAAB